Evidence map›Paper›PMID 36381614›Full record

ArticleOpen forum infectious diseases2022

At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area.

Ann E Woolley, Scott Dryden-Peterson, Andy Kim, Sarah Naz-McLean, Christina Kelly, Hannah H Laibinis, Josephine Bagnall, Jonathan Livny, Peijun Ma, Marek Orzechowski and 5 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Ann E WoolleyDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Scott Dryden-PetersonDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Andy KimDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Sarah Naz-McLeanDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Christina KellyDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Hannah H LaibinisBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Josephine BagnallBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Jonathan LivnyBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Peijun MaBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Marek OrzechowskiBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
James GomezBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Noam ShoreshBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Stacey GabrielBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Deborah T HungDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Lisa A CosimiDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Broad Institute · USBrigham and Women's Hospital · US

Funding

Covid-19-related cervical cancer treatment interruption and role of neoadjuvant chemotherapyR01CA236546 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI DRYDEN-PETERSON, SCOTT · 2019 to 2023
$2.5M
NCI NIH HHS R01 CA236546
6 · The paper itself

Abstract

Background: Unbiased assessment of the risks associated with acquisition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to informing mitigation efforts during pandemics. The objective of our study was to understand the risk factors for acquiring coronavirus disease 2019 (COVID-19) in a large prospective cohort of adult residents in a large US metropolitan area. Methods: We designed a fully remote longitudinal cohort study involving monthly at-home SARS-CoV-2 polymerase chain reaction (PCR) and serology self-testing and monthly surveys. Results: Between October 2020 and January 2021, we enrolled 10 289 adults reflective of the Boston metropolitan area census data. At study entry, 567 (5.5%) participants had evidence of current or prior SARS-CoV-2 infection. This increased to 13.4% by June 15, 2021. Compared with Whites, Black non-Hispanic participants had a 2.2-fold greater risk of acquiring COVID-19 (hazard ratio [HR], 2.19; 95% CI, 1.91-2.50; Conclusions: These results demonstrate that race/ethnicity and socioeconomic status are the biggest determinants of acquisition of infection. This disparity is significantly underestimated if based on PCR data alone, as noted by the discrepancy in serology vs PCR detection for non-White participants, and points to persistent disparity in access to testing. Medical conditions and advanced age, which increase the risk for severity of SARS-CoV-2 disease, were associated with a lower risk of COVID-19 acquisition, suggesting the importance of behavior modifications. These findings highlight the need for mitigation programs that overcome challenges of structural racism in current and future pandemics.

Indexed as

at-home testingCOVID-19risk factorsSARS-CoV-2seroprevalence

Identifiers

PMID36381614
PMCPMC9619609
OpenAlexW4302027500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.